Cargando…

Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis

(1) Background: Cognitive impairment (CI) begins early in the evolution of multiple sclerosis (MS) but may only become obvious in the later stages of the disease. Little data is available regarding predictive biomarkers for early, active cognitive decline in relapse remitting MS (RRMS) patients. (2)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiu, Vlad Eugen, Popescu, Bogdan Ovidiu, Enache, Iulian Ion, Tiu, Cristina, Terecoasa, Elena, Panea, Cristina Aura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689215/ https://www.ncbi.nlm.nih.gov/pubmed/36359416 http://dx.doi.org/10.3390/diagnostics12112571

Ejemplares similares

Predictive MRI Biomarkers in MS—A Critical Review
por: Tiu, Vlad Eugen, et al.
Publicado: (2022)

Serum Neurofilaments and OCT Metrics Predict EDSS-Plus Score Progression in Early Relapse-Remitting Multiple Sclerosis
por: Tiu, Vlad Eugen, et al.
Publicado: (2023)

Pre-Hospital Delay in Acute Ischemic Stroke Care: Current Findings and Future Perspectives in a Tertiary Stroke Center from Romania—A Cross-Sectional Study
por: Terecoasă, Elena Oana, et al.
Publicado: (2022)

Cranial cerebrospinal fluid leak and intracranial hypotension syndrome – a case report
por: Radu, Razvan Alexandru, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of In-Hospital Mortality in Patients with Acute Intracerebral Hemorrhage
por: Radu, Răzvan Alexandru, et al.
Publicado: (2021)

Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events
por: Badea, Raluca Ştefania, et al.
Publicado: (2023)

Transient Global Amnesia After Cerebral Angiography With Iomeprol: A Case Report
por: Tiu, Cristina, et al.
Publicado: (2016)

Opsoclonus-Myoclonus Syndrome Associated With West-Nile Virus Infection: Case Report and Review of the Literature
por: Radu, Răzvan Alexandru, et al.
Publicado: (2018)

Celebrating the legacy of Prof. Ovidiu Alexandru Bajenaru
por: Muresanu, Dafin, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Patients with Intracerebral Hemorrhage – A Feasibility Study on Romanian Patients
por: Radu, Razvan Alexandru, et al.
Publicado: (2020)

Academia steps up to strengthen health policymaking in Romania: a roadmap for tackling difficulties encountered by Ministry of Health specialty commissions
por: Muresanu, Dafin, et al.
Publicado: (2021)

Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly Diagnosed RRMS Patients
por: Pitteri, Marco, et al.
Publicado: (2019)

Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
por: Dragusin, Andreea, et al.
Publicado: (2021)

Correction to: Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
por: Dragusin, Andreea, et al.
Publicado: (2022)

Comparison of plasma and CSF biomarkers in predicting cognitive decline
por: Aschenbrenner, Andrew J., et al.
Publicado: (2022)

A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study
por: Mattioli, Flavia, et al.
Publicado: (2015)

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson’s Disease
por: Morris, Rosie, et al.
Publicado: (2017)

High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients
por: Schneider-Hohendorf, Tilman, et al.
Publicado: (2020)

Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients – An In Vitro Study
por: Dobreanu, Minodora, et al.
Publicado: (2021)

Glial decline and loss of homeostatic support rather than inflammation defines cognitive aging
por: Verkhratsky, Alexei, et al.
Publicado: (2021)

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2022)

Sulfiredoxin-1 blood mRNA expression levels negatively correlate with hippocampal atrophy and cognitive decline
por: Cucos, Catalina Anca, et al.
Publicado: (2022)

Oral available agents in the treatment of RRMS
por: Aupérin, Thierry
Publicado: (2013)

The Comparison of the Selected Parameters of Brain Injury and Interleukins in the CSF in Patients Diagnosed De Novo with RRMS Compared to the Control Group
por: Adamczyk, Bożena, et al.
Publicado: (2023)

Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis
por: Baijot, Johan, et al.
Publicado: (2022)

A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care
por: Xu, Zijun, et al.
Publicado: (2020)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
por: Lerche, Stefanie, et al.
Publicado: (2023)

Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2023)

CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2023)

Network controllability solutions for computational drug repurposing using genetic algorithms
por: Popescu, Victor-Bogdan, et al.
Publicado: (2022)

Impaired Cardiac Function in Patients with Multiple Sclerosis by Comparison with Normal Subjects
por: Mincu, Raluca Ileana, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS
por: Ghezzi, Angelo, et al.
Publicado: (2019)

Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only
por: Kalra, S, et al.
Publicado: (2020)

Cognitive Offloading Does Not Prevent but Rather Promotes Cognitive Development
por: Carvalho, Jônata Tyska, et al.
Publicado: (2016)

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
por: Hunt, Aoife, et al.
Publicado: (2006)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2022)

Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vbppk71ehhvd9pb3p67o5o44uq